The Magazine for Sleep Professionals
Thursday, March 26, 2026
Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, is pleased to announce that the publication of AEGIS clinical trial results is in press at the ERJ Open Research. The objective of the trial was to determine whether patients with mild obstructive sleep apnea (OSA) would […]
Signifier Medical Technologies LLC has announced its partnership with Sunrise, a health tech company that offers a quick and easy way to help in the diagnosis of sleep apnea from home. This collaboration combines Sunrise’s cutting-edge artificial intelligence solutions and the innovative technologies of daytime sleep apnea therapy, eXciteOSA, to […]
Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announces the FDA approval to remove dental contraindications for eXciteOSA. This opens the door for doctors and other providers to prescribe eXciteOSA on a more widespread basis. Based on an observational study conducted by Signifier Medical, the […]
Signifier Medical Technologies Ltd, has announced it has hit the 50,000 therapy session milestone with its innovative eXciteOSA® sleep device. Following FDA authorization and clearance for marketing in February 2021, eXciteOSA has been quickly adopted by physicians and patients alike. The first of its kind, eXciteOSA is a daytime treatment for snoring and mild obstructive […]
Signifier Medical Technologies, an innovator in the sleep-disordered breathing market, announced that eXciteOSA®, the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring, has received the prestigious GOOD DESIGN® Award in the Medical category. The device was recently approved by the U.S. Food and Drug Administration […]
Signifier Medical Technologies, an innovator in the sleep-disordered breathing market, today announced that eXciteOSA®, the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring, has been cleared by the U.S. Food and Drug Administration (FDA), giving millions of sufferers in the U.S. access […]
Senior appointment in the US paves the way for the creation of USA operations in preparation for commercialization of eXciteOSA® and Snoozeal®, novel, non-invasive, daytime therapies for sleep-disordered breathing conditions Signifier Medical Technologies (“Signifier”), an innovator in the sleep-disordered breathing market, is pleased to announce the appointment of Philip Hess as […]
